1

Ponaxen-15/45mg-Ponatinib | Leukemia Targeted Therapy - Meds For Cancer

 News Discuss 
Ponaxen 15 45mg Ponatinib is a multi targeted tyrosine kinase inhibitor for treating CML and Ph ALL, targeting CML with the T315I mutation. https://medsforcancer.com/product/ponaxen-15-45mg-ponatinib

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News